$SRPT Headlines 7 gut checks before the stock market's

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2013 at 6:22 PM

$SRPT Headlines

7 gut checks before the stock market's opening bell 7:54 a.m. July 25, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:00 a.m. July 24, 2013 - Shawn Langlois
Sarepta up 21% on plans to submit drug application 6:55 a.m. July 24, 2013 - Sara Sjolin
Ignore your feelings, obey the market 12:15 p.m. July 23, 2013 - The Trading Deck
For stock speculators, it’s down to two choices 11:10 a.m. June 27, 2013 - The Trading Deck
5 stocks insiders are betting on 11:15 a.m. June 25, 2013 - Insider Monkey
How to get the Nasdaq out of neutral 2:11 p.m. June 18, 2013 - The Trading Deck
Tuesday’s movers: Apple snaps 3-day losing streak 4:09 p.m. April 16, 2013 - Sue Chang
The market that can do no wrong? 10:14 a.m. March 26, 2013 - The Trading Deck
6 stocks positioning for breakouts 8:53 a.m. March 15, 2013 - The Trading Deck
3 speculative names for a market stuck in neutral 8:49 a.m. March 14, 2013 - The Trading Deck
Caesars, Zynga among charts to watch today 1:50 p.m. Feb. 28, 2013 - The Trading Deck
13 stocks for ’13 6:16 p.m. Jan. 3, 2013 - The Trading Deck
Dow, Nasdaq return to scene of the breakdown 12:02 p.m. Nov. 27, 2012 - Michael Ashbaugh
Dow, Nasdaq return to scene of the breakdown 11:46 a.m. Nov. 27, 2012 - Michael Ashbaugh
Charting the S&P 500’s precarious position 12:20 p.m. Nov. 13, 2012 - Michael Ashbaugh
Charting the S&P 500’s precarious position 11:46 a.m. Nov. 13, 2012 - Michael Ashbaugh
Charting the Election Day backdrop 12:09 p.m. Nov. 6, 2012 - Michael Ashbaugh
Charting the Election Day backdrop 11:34 a.m. Nov. 6, 2012 - Michael Ashbaugh
Nasdaq retesting the 200-day moving average 11:10 a.m. Oct. 25, 2012 - Michael Ashbaugh

Searching for Clarity 4:31 p.m. Today - RealMoney.com
FDA Wants More Testing of Muscular-Dystrophy Drug 4:23 p.m. Today - WSJ.com
Stocks Slip on Lackluster Earnings as Fed's Fisher Signals Pullback 4:21 p.m. Today - TheStreet.com
Sarepta Therapeutics' CEO Discusses Q3 2013 Results - Earnings Call Transcript 2:45 p.m. Today - Seeking Alpha
Analysts: Macy’s Estimates Are Overly Optimistic and 3 More Research Notes to Look Through 1:29 p.m. Today - Wall St. Cheat Sheet
Signs of a Turning Point? 1:20 p.m. Today - RealMoney.com
Sarepta Therapeutics Plunges On Negative FDA Report 1:20 p.m. Today - Investors Business Daily
Sarepta Therapeutics: FDA Considers NDA Filing for Eteplirsen "Premature" 11:59 a.m. Today - benzinga.com
GlaxoSmithKline Drug Falls Short, Sarepta Shares Collapse, and 3 More Hot Stocks 11:56 a.m. Today - Wall St. Cheat Sheet
Confusing Action 10:52 a.m. Today - RealMoney.com
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen (Updated) 10:25 a.m. Today - TheStreet.com
UPDATE: Piper Jaffray Downgrades Sarepta Therapeutics After FDA Reverses View on Eteplirsen NDA Filing 9:41 a.m. Today - benzinga.com
Sarepta Therapeutics, Inc. Discusses Q3 2013 Results (Webcast) 7:55 a.m. Today - Seeking Alpha
Heavy Early Morning Activity On Sarepta Therapeutics (SRPT) 7:52 a.m. Today - TheStreet.com
10-Q: SAREPTA THERAPEUTICS, INC. 7:03 a.m. Today - Edgar Online - (EDG = 10Q, 10K)
Sarepta Therapeutics Announces FDA Considers NDA Filing for Eteplirsen Premature 6:09 a.m. Today - benzinga.com
A Rebuttal Of The Sarepta Bull Rebuttal 6:06 a.m. Nov. 6, 2013 - Seeking Alpha
Why I'm More Confident in Sarepta Than Ever Before 10:06 a.m. Nov. 4, 2013 - TheStreet.com
3 Promising Biotech Stocks with Upcoming Catalysts 9:16 a.m. Nov. 4, 2013 - Wall St. Cheat Sheet
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 11:48 a.m. Nov. 1, 2013 - Seeking Alpha

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sarepta Therapeutics, Inc. 3:00 p.m. Today - PR Newswire
SRPT, HOLX, QUIK and VNDA added to NASDAQ Active Stock Watch List at GSR 10:21 a.m. Today - ACCESSWIRE
Sarepta Therapeutics Announces Third Quarter 2013 Financial Results and Recent Corporate Developments 7:01 a.m. Today - Marketwire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
Sarepta Therapeutics to Announce Third Quarter 2013 Financial Results and Corporate Update on November 12, 2013 8:30 a.m. Oct. 24, 2013 - Marketwire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 9:05 a.m. Oct. 21, 2013 - PR Newswire
Parent Project Muscular Dystrophy and Sarepta Therapeutics Join Forces on Genetic Testing Program for Patients With Duchenne Muscular Dystrophy 8:31 a.m. Oct. 17, 2013 - Marketwire
Sarepta Therapeutics to Host Webcast and Conference Call for the Duchenne Muscular Dystrophy Community on October 17, 2013 4:30 p.m. Oct. 10, 2013 - Marketwire
Critical Alerts For Coca-Cola, Biogen Idec, Hewlett-Packard, Yum! Brands, and Sarepta Therapeutics Released By InvestorsObserver 9:31 a.m. Oct. 8, 2013 - PR Newswire
Cellular Biomedicine Has Multiple Near-Term Catalysts 10:27 a.m. Oct. 3, 2013 - ACCESSWIRE
Sarepta Therapeutics Introduces Online Resource Center on Exon Skipping for the Duchenne Muscular Dystrophy Community 8:31 a.m. Oct. 2, 2013 - Marketwire
Sarepta Therapeutics Announces Eteplirsen Demonstrates Continued Stability on Walking Test Through 96 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy 8:30 a.m. Sept. 26, 2013 - Marketwire
Technical Study: Cell Therapeutics Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc., and Medivation Inc. 8:52 a.m. Sept. 25, 2013 - PR Newswire
SRPT, FB, CRUS and OMER added to NASDAQ Active Stock Watch List at GSR 9:02 a.m. Sept. 24, 2013 - ACCESSWIRE
Insider Trading Research for Sarepta Therapeutics, QUALCOMM, Sirius XM Radio, Yahoo, Annaly Capital Management, and Bank of America 8:55 a.m. Sept. 23, 2013 - PR Newswire
Five Star Equities Issues New Research Reports on CYCC, RNA, RVP and SRPT 8:40 a.m. Sept. 23, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 8:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Critical Alerts For Exxon Mobil, Home Depot, JC Penney, Southern Copper, and Sarepta Therapeutics Released By InvestorsObserver 9:31 a.m. Sept. 4, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on MTX, PSMI, SCSS and SRPT 9:00 a.m. Aug. 28, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lung Cancer Awareness Month: United for Progress

A Concerted Effort for Lung Cancer Awareness Picture this: communities nationwide rallying together, not just to remember but to act against lung cancer. That's exactly what's happening this November, as LUNGevity Foundation spearheads Lung Cancer Awareness Month (LCAM). It’s not just about recognition—it's action with purpose. Driving Change Through Action This...

Marco's Pizza Sets Sights on Major Franchise Growth

Marco's Pizza is making waves in the franchising world, and it's not just because they're slinging dough to eager customers. You might want to pay attention to this Toledo-based dynamo as it lands yet again on the Franchise Times Top 400 list for 2026. This ranking, mind you, is no small potatoes; it's the real deal, vetted through a rigorous five-month process that spots...

ADC Therapeutics Preps Financial Results Release

ADC Therapeutics: Eyes on the Financial Prize So here we are, folks—ADC Therapeutics is blitzing the stage and gearing up to spill the beans on their third-quarter saga come November 9, 2026. Who needs a crystal ball when you've got a press release to dissect every number and nuance? Anticipating the Numbers: What's at Stake? ADC Therapeutics has been riding the wave of...

Tennessee Highlights Alarming COPD Rates This November

Tennessee Turns the Spotlight on COPD Here we are again, looking at Tennessee with its weary lung health woes. Governor Bill Lee's newest proclamation for November as COPD Awareness Month is shining a light on a crisis that's been disproportionately hitting the state harder than a sideswipe from a semi. Why the Proclamation Matters Let's cut through the fog—COPD,...

PSEG Q3 2026: Mixed Earnings Amidst Storms and Stability

Decoding PSEG's Q3 2026 Performance A company's quarterly performance can feel a bit like checking the weather: you are never quite sure what's coming your way. For PSEG's (NYSE: PEG) third quarter of 2026, the skies were full of mixed signals. Just looking at the headline earnings number, $0.76 per share in net income, there's a drop from last year's $1.24. That’s a...

UPM-Kymmene Finalizes Demerger: WISA Group to Nasdaq

UPM-Kymmene Shakes Things Up Here's the meat and potatoes: UPM-Kymmene Corporation is going through a big change. They've decided to cut a part of themselves off and send it out into the world. This partial demerger has been registered, and now WISA Group Plc is stepping out from UPM's shadow. Where to? They're headed for the big league, getting listed on Nasdaq Helsinki....

Curaleaf Takes Stake in NJ's Boone Town Dispensary

Curaleaf's Bold Move in the Garden State Curaleaf Holdings, Inc. is doubling down on its cannabis bet in New Jersey. The acquisition of an equity stake in Boone Town Provisions, located at 677 Myrtle Ave., Boonton, NJ, boosts Curaleaf’s dispensary count to four in the state. The company's not just wandering on the map; it's pinpointing high-performing locations to...

Big Wins for Small Operations: The Greenworks Gamble Here's something that'll make any grass-whisperer perk up. Greenworks® Commercial, known for their battery-centered machinery, juiced some serious goodwill at the Equip Exposition 2026. They coughed up nearly $34,000 in gear, dishing out prizes like really expensive candy at a lawn-care carnival. Lucky Draw Brings...

YeePay's B2B Payment Innovations Target Airlines' Pain Points

A New Takeoff for Airline B2B Payments Dusting off the cobwebs of traditional payment processes, YeePay has been busy at the 2026 IATA WFS & WPS, held on the glitzy floor of the Galaxy International Convention Center in Macau from October 28 to 29. They're not just chatting about travel; they're rolling out a novel way to tackle the headaches in airline B2B order...

HIZENERGY Sustains Tier 1 Status Amid Tighter Criteria

Another Feather in HIZENERGY's Cap In a landscape where credibility can make or break a business, HIZENERGY has once again staked its claim as a powerhouse. Come Q4 2026, and despite a rougher sea to navigate with BloombergNEF’s (BNEF) upgraded Tier 1 criteria, the company held its own. For those unacquainted, securing a place on this lofty list involves some serious...